Cancer is a leading cause of death worldwide. Currently available therapies are inadequate
and spur demand for improved technologies. Rapid growth in nanotechnology towards the …

The research on porous silicon (PSi) materials for biomedical applications has expanded
greatly since the early studies of Leigh Canham more than 25 years ago. Currently, PSi …

Nanocarrier and exosome encapsulation has been found to significantly increase the
efficacy of targeted drug delivery while also minimizing unwanted side effects. However, the …

Nanomaterials provide a unique platform for the development of theranostic systems that
combine diagnostic imaging modalities with a therapeutic payload in a single probe. In this …

The exploitation of mesoporous silica nanoparticles (MSNs) as drug delivery systems has
grown exponentially due to their remarkable tunable properties, such as high surface area …

Nanoparticulate drug delivery systems offer remarkable opportunities for clinical treatment.
However, there are several challenges when they are employed to deliver multiple …

Luminescent porous silicon nanoparticles with mean size of about 100 nm were covered by
biodegradable polymer (dextran) and were investigated as potential sensitizers for …

Cancer cannot be controlled by the usage of drugs alone, and thus, nanotechnology is an
important technique that can provide the drug with an impetus to act more effectively. There …

Introduction: Porous silicon (pSi) engineered by electrochemical etching has been used as a
drug delivery vehicle to address the intrinsic limitations of traditional therapeutics …

Porous silicon (PSi) based particulate systems are emerging as an important drug delivery
system due to its advantageous properties such as biocompatibility, biodegradability and …